FEops Revenue and Competitors

Ghent,

Location

N/A

Total Funding

3D

Industry

Estimated Revenue & Valuation

  • FEops's estimated annual revenue is currently $8.1M per year.(i)
  • FEops's estimated revenue per employee is $153,000

Employee Data

  • FEops has 53 Employees.(i)
  • FEops grew their employee count by -2% last year.

FEops's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
Chief Technology OfficerReveal Email/Phone
3
Director for Business DevelopmentReveal Email/Phone
4
QARA ManagerReveal Email/Phone
5
Development managerReveal Email/Phone
6
Case ManagerReveal Email/Phone
7
Principal R&D EngineerReveal Email/Phone
8
R&D EngineerReveal Email/Phone
9
Full-stack DeveloperReveal Email/Phone
10
Principal R&D EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.4M114-37%N/AN/A
#2
$1.1M110%N/AN/A
#3
$5.6M41N/AN/AN/A
#4
$5780M77268%N/AN/A
#5
$9.9M655%N/AN/A
#6
$41.7M22324%N/AN/A
#7
$24270M2786321%$4BN/A
#8
$207.3M871N/AN/AN/A
#9
$4M528%N/AN/A
#10
$4.2M31N/AN/AN/A
Add Company

What Is FEops?

Privately held FEops, headquartered in Gent, Belgium, has developed FEops HEARTguide™, a proprietary system to improve transcatheter valve procedures based on personalized computer simulations. “FEops HEARTguide™ is available on the European and Canadian market with indication for use in TAVI and LAAo and is currently the only technology on the market that predicts how a TAVI or LAAo implant will interact with the patient-specific anatomy and thus provide clinically meaningful insights in the personalized device size selection and position.” FEops' pipeline extends to dedicated planning tools with unique potential in driving forward the development, testing and market adoption of new and improved device-based solutions in the structural heart space.

keywords:N/A

N/A

Total Funding

53

Number of Employees

$8.1M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

FEops News

2022-04-06 - FEops Heartguide receives FDA clearance for LAAO planning ...

FEops has announced that it received authorisation from the US Food and Drug Administration (FDA) for FEops Heartguide pre-operative...

2022-03-30 - FEops HEARTguide Receives FDA Clearance for LAAo ...

Privately held FEops, headquartered in Gent, Belgium, is a digital health player streamlining structural heart disease management. In September...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.4M5410%N/A
#2
$7M54-8%N/A
#3
N/A5743%N/A
#4
$13.1M619%N/A
#5
$11.2M629%N/A